The Valley News reports in December 2010, the company bought the plant, and other equipment related to the making of OP-1, a protein-based putty used to regenerate bones for treating spinal, hip and knee conditions, from Stryker Biotech.

But OP-1 never met the company's expectations. Last year, Olympus began offering the plant for contract manufacturing to help other firms develop biotech products.